Diabetes and hyperglycemia are poor prognostic factors of endometrial cancer, and in vitro insulin responsiveness and enhanced proliferation of endometrial cancer cells have also been reported [1,2,13,14,20,21]. The gene discussed is INS; the disease is diabetes mellitus.